|
|
||||||||
The Journal of Medical Microbiology, Vol 47, Issue 4 303-308, Copyright © 1998 by Society for General Microbiology
JOURNAL ARTICLE |
T. Matsumoto, K. Tateda, N. Furuya, S. Miyazaki, A. Ohno, Y. Ishii, Y. Hirakata and K. Yamaguchi
Department of Microbiology, Toho University School of Medicine, Tokyo, Japan.
The protective efficacies of vaccines prepared from Pseudomonas aeruginosa alkaline protease, elastase and exotoxin A toxoids against gut-derived P. aeruginosa sepsis in mice were evaluated. Specific pathogen-free mice given P. aeruginosa strain D4 orally followed by cyclophosphamide (to promote translocation across the gut wall) died of bacteraemia. Mice immunised with one of the three individual toxoid vaccines were not significantly protected when compared to control mice immunised with bovine serum albumin. Combined immunisation with alkaline protease and elastase toxoids likewise showed no significant protective activity. However, combined immunisation with alkaline protease and exotoxin A toxoids significantly increased the survival rate, which reached 60% (compared with a 7.1% survival rate in the control group). These results show that alkaline protease and exotoxin A play important roles as pathogenic factors in gut-derived sepsis and that a combination of the two exoenzyme toxoids represents a logical candidate for vaccination against P. aeruginosa sepsis.
This article has been cited by other articles:
![]() |
R. Watanabe, T. Matsumoto, G. Sano, Y. Ishii, K. Tateda, Y. Sumiyama, J. Uchiyama, S. Sakurai, S. Matsuzaki, S. Imai, et al. Efficacy of Bacteriophage Therapy against Gut-Derived Sepsis Caused by Pseudomonas aeruginosa in Mice Antimicrob. Agents Chemother., February 1, 2007; 51(2): 446 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hertle, R. Mrsny, and D. J. Fitzgerald Dual-Function Vaccine for Pseudomonas aeruginosa: Characterization of Chimeric Exotoxin A-Pilin Protein Infect. Immun., November 1, 2001; 69(11): 6962 - 6969. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsumoto, K. Tateda, S. Miyazaki, N. Furuya, A. Ohno, Y. Ishii, Y. Hirakata, and K. Yamaguchi Effect of Antiflagellar Human Monoclonal Antibody on Gut-Derived Pseudomonas aeruginosa Sepsis in Mice Clin. Vaccine Immunol., July 1, 1999; 6(4): 537 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsumoto, K. Tateda, S. Miyazaki, N. Furuya, A. Ohno, Y. Ishii, Y. Hirakata, and K. Yamaguchi Fosfomycin Alters Lipopolysaccharide-Induced Inflammatory Cytokine Production in Mice Antimicrob. Agents Chemother., March 1, 1999; 43(3): 697 - 698. [Abstract] [Full Text] |
||||
![]() |
T. Matsumoto, K. Tateda, S. Miyazaki, N. Furuya, A. Ohno, Y. Ishii, Y. Hirakata, and K. Yamaguchi Effect of Interleukin-10 on Gut-Derived Sepsis Caused by Pseudomonas aeruginosa in Mice Antimicrob. Agents Chemother., November 1, 1998; 42(11): 2853 - 2857. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |